Chen et al. investigated the therapeutic adjuvant efficacy of PLGA NPs encapsulating near-infrared (NIR) dye indocyanine green (ICG) and R837 in anti-CTLA-4 therapy for both breast and colon cancer [105]. The gene discussed is CTLA4; the disease is malignant colon neoplasm.